ICYMI: Recent survey adds to growing body of research on barriers to innovative payment approaches

 Arecent study conducted by the Academy of Managed Care Pharmacy (AMCP) and Xcenda found that 71 percent of insurers and 63 percent of biopharmaceutical companies surveyed were interested in pursuing outcomes-based contracts, one type of value-based contract (also known asresults-based contracts or RBCs).
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Value-Driven Health Care The Value Collaborative Source Type: news